May 19, 2014

Aerocrine, a medical technology company with a focus on improving the treatment of patients with inflamed airways, announced that Health Care Services Corp. will begin covering fractional exhaled Nitric Oxide (FeNO) testing, which is used to diagnose and manage asthma.

May 19, 2014

Supplemental vitamin C taken by pregnant smokers improved measures of lung function for newborns and decreased the incidence of wheezing for infants through 1 year, according to a study published by JAMA that was released Sunday.

May 16, 2014

The Food and Drug Administration on Thursday announced it required Sunovion Pharmaceuticals, manufacturer of the sleep drug Lunesta (eszopiclone), to change the drug label and lower the current recommended starting dose.

May 15, 2014

In keeping with the trend, Finnish beauty brand Lumene was certain to add a new skin care oil to its list of launches for 2014.

Among the new products added this year to Lumene’s Vitamin C+ collection, which is now known as Bright Now Vitamin C+, is the new Bright Now Vitamin C Dry Skin Cocktail skin oil.

May 15, 2014

From removing makeup to cleaning “boogies” from a baby’s nose, wipes and moist towelettes continue to strengthen their foothold in beauty and personal care.

May 15, 2014

Actavis has reached an agreement with Janssen Pharmaceuticals to continue supplying the authorized generic version of Janssen's Concerta (methylphenidate hydrochloride extended-release tablets), the company announced.

May 15, 2014

Bioré, a Kao USA beauty brand, is leveraging the power of charcoal with its new Bioré Skincare line, which includes a self-heating, one-minute facial mask.

May 15, 2014

Nordic Naturals introduced Vitamin C Gummies, providing 250 mg of vitamin C. With a tart tangerine flavor, Vitamin C Gummies are chewable gummy slices for kids 4 years and older.

May 15, 2014

The results of two recent studies support the financial healthcare savings of using supplements.

May 14, 2014

Actavis on Tuesday announced that it has received final approval from the Food and Drug Administration on its abbreviated new drug application for a generic version of Mallinckrodt's Exalgo (hydromorphone hydrochloride extended-release tablets 8 mg, 12 mg and 16 mg).

May 14, 2014

Dr. Reddy’s Laboratories on Tuesday posted $2.2 billion in annual sales for the fiscal year ended March 31, representing growth of 14%.

May 14, 2014

Mylan on Wednesday announced that it has launched olanzapine orally disintegrating tablets in 5-mg, 10-mg, 15-mg and 20-mg strengths. The drug is the generic version of Zyprexa Zydis tablets from Eli Lilly and Co.

May 13, 2014

Valeant Pharmaceuticals on Monday announced that certain of its subsidiaries have entered into settlement agreements with Actavis related to Actavis' generic versions of Tiazac XC.

May 12, 2014

Actavis on Monday announced that it has entered into an agreement with Valeant Pharmaceuticals International to settle all outstanding patent litigation related to Actavis' generic version of Acanya (clindamycin phosphate and benzoyl peroxide) Gel, 1.2%/2.5%.

May 9, 2014

Ajanta Pharma USA on Friday announced the launch of risperidone tablets (0.25-mg, 0.5-mg, 1-mg, 2-mg, 3-mg and 4-mg), the generic version of Risperdal.

May 9, 2014

Bayer agreed to acquire the consumer care business of U.S. pharmaceutical company Merck for a purchase price of $14.2 billion. The OTC acquisition will give Bayer the global No. 2 position in nonprescription products following recently announced consolidations in this growing healthcare industry segment, and will significantly enhance Bayer’s business across multiple therapeutic categories and geographies. Merck's consumer care business includes such leading brands as Claritin, Coppertone and Dr. Scholl’s. Pro forma sales of the combined businesses in 2013 amounted to $7.4 billion with Merck’s business contributing approximately $2.2 billion.

Upon completion of the acquisition, Bayer is expected to achieve global leadership positions in dermatology and gastrointestinals and advance to the No. 2 position in the cold, allergy, sinus and flu category. Bayer will remain No. 2 in nutritionals and No. 3 in analgesics. Overall, the proposed GlaxoSmithKline-Novartis combination represents the largest consumer health business with about 5.7% share, according to reports. The Bayer/Merck combination comes in second with around 4.5% share. McNeil Consumer rounds out the top three globally with a share just above 4%.

May 9, 2014

One thing remains unchanged about our nurse practitioner and physician assistant readers: Retail clinicians tend to love their jobs.

May 9, 2014

CorePharma on Thursday announced the launch of methylphenidate hydrochloride tablets USP, the generic version of Ritalin from Novartis.

May 9, 2014

Enaltus recently announced three new additions to its line of ScarAway scar removal products.

May 8, 2014

Actavis announced that it has launched a generic version of Boehringer Ingelheim's Catapres-TTS (clonidine transdermal system, USP, 0.1-mg/day, 0.2-mg/day, and 0.3-mg/day for one week).

May 8, 2014

Although some guidelines recommend lipid screening for children and adolescents of certain ages, data indicate that only about 3% are having their cholesterol tested during health visits, according to a study in the May 7 issue of JAMA, a theme issue on child health.

May 7, 2014

M&M Products Co. has expanded its Nothing But product line with the recent debut of Nothing But’s Melted Shea Butter Leave-In Conditioner.

May 7, 2014

Mitchum has expanded its portfolio with the 2014 launch of Mitchum Clinical, the brand’s only soft solid with the odor-fighting benefits of oxygen odor-control technology.

May 6, 2014

AstraZeneca on Tuesday announced the Food and Drug Administration approved Epanova (omega-3-carboxylic acids) as an adjunct to diet to reduce triglyceride levels in adults with severe hypertriglyceridemia (triglyceride levels greater than or equal to 500 mg/dL).